Clinical Trial Update: Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combination of pegylated interferon and ribavirin in patients with chronic hepatitis C who have persistently normal A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: University of Turin, Italy | Conditions: Chronic Hepatitis C | Phase 4 | Status: UNKNOWN